Prenylated indole alkaloids are hybrid natural products derived from prenyl diphosphates and tryptophan or its precursors and widely distributed in filamentous fungi, especially in the genera Penicillium and Aspergillus of ascomycota. These compounds represent a group of natural products with diverse chemical structures and biological activities. Significant progress on their biosynthesis has been achieved in recent years by identification of biosynthetic geneclusters from genome sequences and by molecular biological and biochemical investigations. In addition, a series of prenylated indole derivatives have been produced by chemoenzymatic synthesis using overproduced and purified enzymes.
Shu-Ming Li
Shu-Ming Li is full professor of Pharmaceutical Biology at the Philipps-University in Marburg, Germany. He received his Ph.D. in 1992 from the Rheinische Friedrich-Wilhelms-University in Bonn, Germany. He has served as associate professor for Pharmaceutical Biology at the Heinrich-Heine-University in Düsseldorf. His research interests focus on the genomics of the biosynthesis of secondary metabolites in fungi, especially of prenylated indole alkaloids.
1 Introduction
Prenylated indole alkaloids are hybrid natural products containing indole/indoline and isoprenoid moieties or structures derived thereof. They are widely distributed in terrestrial and marine organisms, especially in the genera Penicillium and Aspergillus of ascomycota, and display broad structure diversity. These compounds often carry biological and pharmacological activities distinct from their non-prenylated aromatic precursors.1–3
The availability of the genome sequences of bacteria and fungi, which has increased tremendously in recent years,4,5 has accelerated the identification of genes involved in the biosynthesis of secondary metabolites by genome mining.6–8 By using this strategy, biosynthetic genes of several prenylated indole derivatives were identified in the genome sequences of ascomycetes.9–11 The functions of these genes have been proven by molecular biological and biochemical approaches.9,10 Additionally, a number of prenylated simple indole derivatives or tryptophan-containing diketopiperazines were synthesised by using overproduced and purified indole prenyltransferases.12 The aim of this review is to give an overview on the structural characteristics of the main classes of prenylated indole derivatives from fungi, without listing all the structures of known natural products. In addition, this review summarizes briefly the considerable progress on the molecular biological and biochemical investigations on the biosynthesis of prenylated indole alkaloids in recent years and the application of the recombinant proteins for the production of prenylated indole derivatives.
2 Diverse structures of prenylated indole derivatives from fungi with significant pharmacological and biological activities
In the structures of prenylated indole alkaloids, the prenyl moieties can be connected via its C1 or C3 to an aromatic nucleus, which are referred to as regular or reverse prenyl moieties, respectively (Fig. 1). In prenylated cyclic dipeptides and bis(indolyl) benzoquinones, reverse prenyl moieties are usually attached to position N1, C2 or C3 of the indole or indoline ring, while the regular moieties are normally connected to position N1, C2, C5, C6 or C7, but not C3 of the indole or indoline rings (Fig. 1). Interestingly, prenylation at position C4 was only found in structural skeletons derived exclusively from only one L-tryptophan molecule such as in ergot alkaloids and cyclopiazonic acid or indole-diterpenes, but not in peptides or benzoquinones.
Fig. 1 Numbering of prenyl and indole/indoline moieties.
Fungal natural products derived from L-tryptophan and L-proline represent a large group within the prenylated indole alkaloids.3 The common precursor of these compounds is the cyclic dipeptide brevianamide F (1), which is converted to tryprostatin B (2) by attaching a regular prenyl moiety at position C2 or to deoxybrevianamide E (3) by a reverse one. Tryprostatin B (2) is a key intermediate in the biosynthesis of diverse structures such as tryprostatin A (4), spirotryprostatin A (5), fumitremorgins (6–8) and verruculogen (9), while deoxybrevianamide E (3) serves as precursor for brevianamides, e.g. brevianamide A (10), austamide (11) and notoamides (12–14).3,16–18
Fumitremorgin B (7) and verruculogen (9), which contain two prenyl moieties at positions N1 and C2 of the indole ring, are mycotoxins from a number of Aspergillus and Penicillium strains.19–23 Verruculogen (9), associated with Aspergillus fumigatus hyphae and conidia, was reported to be able to modify the electrophysiological properties of human nasal epithelial cells and could be involved in the pathogenesis of this fungus.24 Fumitremorgin A (8) is also a mycotoxin from Aspergillus and Penicillium strains20,25 and contains an additional prenyl moiety, in comparison to the structure of verruculogen (9). The biosynthetic intermediates of these compounds containing one prenyl moiety attached to position C2, such as tryprostatin B (2) and its methoxylated derivative tryprostatin A (4) as well as fumitremorgin C (6), showed biological activities of pharmaceutical interest. For example, tryprostatins A (4) and B (2) as well as their diastereomeres were found to exhibit cytotoxicity towards various cancer cell lines, even more potent than etoposide.26–28 Fumitremorgin C (6) is a specific inhibitor of the breast cancer resistance protein and could reverse the resistance of some tumour cell lines.29–31 Tryprostatin A (4) was also able to inhibit the ABC transporter of the resistant tumour cell lines.32,33
Brevianamides and austamides, e.g. brevianamide A (10) and austamide (11), constitute a small group of cyclo-L-Trp-L-Pro derivatives and contain only one reverse prenyl moiety at position C2 of the indole ring or a structure derived thereof. These compounds are produced by Penicillium brevicompactum and Aspergillus ustus, respectively.34–36 The dimeric cyclic dipeptide brevianamide J (15), containing one reverse prenyl moiety at position C2 of the indole ring in each unit, was recently isolated from cultures of Aspergillus versicolor.37
Notoamides (12–14) and related compounds such as aspergamides, staphacidins and (−)-versicolamide B (16–18) are diprenylated derivatives of cyclo-L-Trp-L-Pro. One of the prenyl residues forms a fused dimethyldihydropyran ring via positions C6 and C7 of the indole ring. The second one was found as an intact reverse prenyl moiety at position C2 (notoamide D 12), C3 (notoamide M 13) or as strongly modified structure elements (notoamide A (14), stephacidin A (16), aspergamide A (17) and (−)-versicolamide (18), which could be considered as rearrangement results of the prenyl moiety at position C2 of the indole ring.38 Stephacidin B (19), a dimeric derivative of stephacidin A (16), has also been described.39 Notoamides, (−)-versicolamide and stephacidins are isolated from different Aspergillus strains.17,18,38–40 Notoamide A (14) showed moderate cytotoxicity against HeLa and L1210 cells.17
2.2 Prenylated derivatives of the cyclic dipeptide consisting of two L-tryptophan molecules
Fellutanines are reversely C2-prenylated derivatives of cyclo-L-Trp-L-Trp. Fellutanines B (20) and C (21) from Penicillium fellutanum are mono- and diprenylated derivatives with an intact diketopiperazine ring,41 while this ring system is fused with the indoline ring in fellutanine D (22) from Penicillium fellutanum and its diastereomer gypsetin (23) from Nannizzia gypsea.42 Amauromine (24) from Amauroascus sp.43 and epiamauromine (25) from Aspergillus ochraceus44 represent reversely C3-prenylated indolines. Okaramines (26–29) from Penicillium simplicissimum and Aspergillus aculeatus consist of at least 18 congeners.45–49 In the structures of the most okaramines, e.g. A (26) and C (27), one reverse prenyl moiety is found at position C2 and a second one at position N1 of another tryptophan unit. These okaramines very likely are derived from cyclo-L-N1-DMAT-L-C2-DMAT (30), which was also isolated from Penicillium simplicissimum.48 In the structure of okaramine L (28), position N1 is regularly prenylated instead. In some cases, the second prenyl residue can also be found at other positions than N1, e.g. in okaramine J (29) at position C7.48
Fellutanine D (22) was reported to be cytotoxic against several cell lines,41 while its diastereomer gypsetin (23) showed cholesterol acyltransferase inhibiting activity.50 Amauromine (24) was reported to have a vasodilating activity.51 Its stereoisomer epiamauromine (25) showed, on the other hand, insecticidal activity.44 Insecticidal activity against silkworms has also been observed with several okaramines.52
All members of this group are derived from cyclic dipeptides containing an indoline ring, which is fused with a diketopiperazine or benzodiazepindinone ring. In addition, they carry reverse prenyl moieties at position C3 of the indoline ring. A prominent example is roquefortine C (31, also called roquefortine) derived from L-tryptophan and L-histidine. This compound was firstly isolated from Penicillium roqueforti53 and identified later in a number of Penicillium strains,54–57 including P. roqueforti strains used for cheese production.53,55 Roquefortine C (31) is also the precursor of several prenylated indole alkaloids such as roquefortine E (32), glandicoline B (33),58 meleagrin (34)58 and oxaline (35).58–60 Roquefortine E (32), containing an additional reverse prenyl moiety attached to the imidazole ring, was isolated from Gymnoascus reessii.61 A meleagrin derivative (36) carrying a modified prenyl moiety at the imidazole ring was recently isolated from a deep ocean sediment derived Penicillium sp.62
A second example from this group is the mycotoxin acetylaszonalenin (37) (called also LL-S490β) derived from the amino acidsL-tryptophan and anthranilic acid. Acetylaszonalenin (37) was isolated initially from an unidentified Aspergillus species,63 Together with its non-acetylated form aszonalenin (38), it was also identified in various fungal strains, e.g. Aspergillus zonatus,64A. fumigatus,65A. carneus66 and Neosartorya fischeri.67,68 Their stereoisomers epi-aszonalenins A (39) and C (40) were isolated from Aspergillus novofumigatus.69
Fructigenine A (41) from Penicillium fructigenum,70 which was also identified as rugulosuvine B in Penicillium regulosum71 is a cyclic dipeptide derivative of L-tryptophan and L-phenylalanine. This compound was reported to be a plant growing inhibitor.70 Until now, no prenylated diketopiperazine derivatives containing tryptophan and tyrosine were isolated from the natural sources.
2.4 Prenylated peptide derivatives containing L-tryptophan and aliphatic amino acids
Prenylated indole alkaloids in this category are mainly derived from L-tryptophan and L-alanine or L-tryptophan and L-isoleucine. Prenylated cyclo-L-Trp-L-Ala derivatives including echinulin (42) or its analogues constitute a large group of fungal metabolites. They carry up to three prenyl moieties with a reverse one at position C2 of the indole ring. Echinulin (42), bearing prenyl moieties at positions C2, C5 and C7, was initially isolated from Aspergillus amstelodami72 and then from different Aspergillus strains.73–76 It should be mentioned that echinulin (42) was also identified in different plants of Anacardiaceae, Cucurbitaceae and Orchidaceae.77,78 Diverse echinulin analogues with different prenylation positions at the benzene ring and modifications, e.g.hydroxylation, oxidation and cyclisation of prenyl moieties were described in literature.74 Examples of such structures are variecolorin L (43) from Aspergillus variecolor with prenyl moieties at positions C2, C4 and C574 or arestrictin B (44) from Aspergillus penicilloides with prenyl moieties at positions C2, C6 and C7.79 A number of mono- and diprenylated cyclo-L-Trp-L-Ala derivatives were also isolated from various fungal strains,73–75e.g. preechinulin (45),73,74 terezine D (46),80 tardioxopiperazines A (47) and B (48).74,81 In the structure of cycloechinulin (49), the prenyl moiety at position C2 is connected to the diketopiperazine ring.82
Astechrome (50) from Aspergillus terreus represents a rare iron-containing prenylated cyclo-Trp-Ala derivative.83 In the structure of 5-N-acetylardeemin (51), which was identified in Neosartorya fischeri var. brasiliensis,84 an anthranilic acid moiety is connected to the diketopiperazine ring consisting of tryptophan and alanine. Variecoloritide B (52) from Aspergillus variecolor contains a prenylated cyclo-Trp-Ala residue, which is condensed with an anthraquinone molecule.85 Fructigenine B (53) from Penicillium fructigenum,70 which was also identified as verrucofortine in Penicillium verucosum var. cyclopium,86 is a prenylated cyclic dipeptide of tryptophan and leucine. Together with fructigenine B (53), five new C3-prenylated derivatives including brevicompanine G (54) were isolated from a deep ocean sediment derived Penicillium sp.87 Brevicompanine G (54) is likely derived from tryptophan and valine. Both amino acids are also found in the structures of the prenylated linear peptides mellamide (55) and terpeptin (56), which were isolated from Aspergillus melleus88 and Aspergillus terreus,89 respectively.
Paraherquamides (57 and 58) and related compounds marcfortines (59 and 60) are a structurally complex family of indole alkaloids. Many members of this group show potent anthelmintic and antinematodal activities and have been under intensive investigation for use in veterinary medicine to treat various intestinal parasites.3 The members of this group are derived from L-tryptophan and β-methylproline, which is in turn formed from L-isoleucine.3 These compounds were identified in early 1980s in Penicillium and Aspergillus strains, especially in Penicillium paraherquei.3,34
Most of the paraherquamides and analogues are diprenylated indole alkaloids. One prenyl moiety is found at position C3 or a structure derived thereof. The second one is connected to positions C6 and C7 of the indole ring via two oxygen atoms forming a seven-membered ring, as in the case of paraherquamide A (57) and macfortine A (59). This prenyl moiety exists also as a dimethyldihydropyran structure, as in the case of paraherquamide F (58) and macfortine C (60).
Asterriquinone (61), a symmetrical benzoquinone containing two reversely N1-penylated tryptophanyl moieties, was isolated from Aspergillus terreus90 and demonstrated to be active against tumour cells.91 Later on, a series of bis(indolyl) benzoquinones carrying one or two regular or reverse prenyl moieties was identified in A. terreus,15,92–94Chaetomium sp.95 and other fungi.96–100 Isoasterriquinone (62) from Aspergillus terreus contains reversely N1-prenylated and regularly C2-prenylated tryptophanyl moieties.94 Hinnuliquinone (63) from Nodulisporium hinnuleum101 is a symmetrical dimer of reversely C2-prenylated tryptophan components. Further examples of symmetrical dimers are asterriquinones CT5 (64) and CT3 (65), isocochliodinol (66) and asterriquinone CT4 (67), with regular prenylation at positions of C2, C5, C6 and C7, respectively. Asterriquinones CT3 (65), CT4 (67) and CT5 (64) were isolated from Humicola grisea, Humicola fuscoatra and Aspergillus terreus, respectively.94,99 Together with isocochliodinol (66), asterriquinones CT3 (65) and CT4 (67), termed cochliodinol and neocochliodinol, respectively, were also identified in a Chaetomium sp.95
In addition to diprenylated derivatives, diverse monoprenylated indolyl benzoquinones were also reported, e.g. semicochliodinols A (68) and B (69) from Chrysophorium merdarium.100 In ochrindole D (70) from Aspergillus ochraceus, the prenyl moiety is not attached to the indole, but to the benzoquinone ring.102 Terrequinone A (71) from Aspergillus terreus and A. nidulans is a bis(indolyl) benzoquinone with a reverse prenyl moiety at position C2 of the indole and a regular one at the quinone ring.97,103 As in the cases of prenylated peptides, no C4-prenylated derivatives were found within the bis(indolyl) benzoquinones.
A number of asterrequinone derivatives showed cytotoxicity.104–107 Investigation on the structure–activity relationship showed that the indole ring is important for the effect.107 Hinnuliquinone (63), semicochliodinols A (68) and B (69) were reported to be active as inhibitors of HIV-1 protease.100,108
2.6 Ergot alkaloids and other C4-prenylated indole alkaloids
Ergot alkaloids are a complex family of toxins and important pharmaceuticals with diverse structures and biological activities.1,109 They are produced by fungi of two orders and plants of three families.110 The important producers are fungi of the genera Claviceps, Penicillium and Aspergillus.1,109 Both natural ergot alkaloids and their semi-synthetic derivatives are in widespread use in modern medicine.1,110 Chemically, ergot alkaloids are characterised by the presence of the tetracyclic ergoline ring (72) and can be divided into two classes according to their structural features, i.e. amide derivatives of D-lysergic acid (73) and the clavine alkaloids.109,111 The members of the first group are usually composed of lysergic acid (73) and an amino alcohol, e.g. ergometrine (74), or a peptide moiety, e.g.ergotamine (75). The clavines like agroclavine (76), festuclavine (77) and fumigaclavine C (78) or their precursors like chanoclavine-I (79) merely consist of a tetracyclic or even tricyclic ring system lacking an amide or a peptide moiety. Ergotamine (75) was described as the first ergot alkaloid in 1920. Since then about 50 different ergot alkaloids of both classes have been found in nature.109,111,112 Due to their significant importance as toxins and drugs, ergot alkaloids have been an important research field in secondary metabolism.111 Results on biology, chemistry, molecular biology and biotechnology have been reviewed extensively.1,109–113
Biogenetically, the ergoline ring (72) is derived from the C4-prenylated tryptophan 4-DMAT (80). This building block was not found in tryptophan-containing diketopiperazine or bis(indolyl) benzoquinone alkaloids discussed above, but in the structures of α-cyclopiazonic acid (81) and rugulovasines (82 and 83). The fungal neurotoxin α-cyclopiazonic acid (CPA) (81), a nanomolar inhibitor of Ca2+-ATPase,114 has a pentacyclic indole tetramic acid scaffold and was firstly isolated from Penicillium cyclopium115 and followed by a large number of Penicillium and Aspergillus strains.57,116–119 α-Cyclopiazonic acid (81) was often found as a contaminant in food and feeds117,119,120 Rugulovasines A (82) and B (83) and their chlorinated derivatives were identified as a small group of C4-prenylated tryptophan derivatives in several Penicillium strains.121–123
Indole-diterpenes with a minimal structure (84) are a large, structurally and functionally diverse group of secondary metabolites produced by filamentous fungi with a common cyclic diterpen backbone and an indole residue.2 The first reported structure of this group, paspalitrem A (85), was isolated from Claviceps paspali in 1977.124 Two years later, the tremorgenic mycotoxin aflatrem (86) was identified in Aspergillus flavus.125,126 These mycotoxins are monoprenylated derivatives of paspalinine (87), which could also be isolated from various fungal strains.124,126 The structures of penitrem A (88) and analogues, a group of tremorgenic mycotoxins identified in several Penicillium strains, including P. crustosum,127–130 were determined in 1981.131 Lolilline (89) and the tremorgenic lolitrems A (90) and B (91) were identified in Neotyphodium-infected plants Lolium perenne and Festuca sp.11,132,133 In the structures of the mentioned compounds, a C19 skeleton derived from a geranylgeranyl moiety is fused to positions C2 and C3 of the indole ring.
Similar structural features were also found in shearinines, e.g. shearinine D (92) from Penicillium strains.134,135 In comparison, indole-diterpenes with a C20 residue attached to indole moiety were also identified, e.g. emindoles PA (93) and PB (94).136 As paspalitrem A (85) and aflatrem (86), the other mentioned structures also carry additional intact or modified prenyl moieties at the indole rings. For example, emindoles PA (93) and PB (94) carry one prenyl moiety at N1 and C2, respectively, while two prenyl residues were found in lolilline (89), and lolitrems A (90) and B (91) at positions C4 and C5. Shearinine D (92) is diprenylated at C5 and C6. In the structures of lolitrem A (90) and B (91), an additional C5 unit is attached to the C19 residue.
In 1997, a potent insecticidal agent nodulisporic acid A (95) was identified in an endophytic fungus Nodulispororium sp. by bioassay-guided isolation.137 Its structure was determined as an indole-diterpene derivative carrying three modified dimethylallyl moieties at position C5, C6 and C7 of the indole ring.137,138 Since then, eighteen nontremorgenic nodulisporic acid derivatives have been isolated from Nodulispororium including the biosynthetic precursors of nodulisporic acid A such as nodulisporic acids B (96), C (97), D (98) and E (99).139–141 All of these compounds are potent anti-flea agents.141 Nodulisporic acids lack the tertiary hydroxyl group at C-9 of the structure (84) that is implicated in the tremorgenic properties of the related alkaloids.142
3.1 Feeding experiments and investigations with crude enzyme extracts
A large variety of feeding experiments with isotope-labelled precursors were carried out for ergot alkaloids in Claviceps,1,111 roquefortine C (31) in Penicillium roquerforti,143 aszonalenin (38) in Aspergillus zonatus,143 echinulin (42) in Aspergillus amstelodami,144 brevianamide A (10) in Penicillium brevicompactum, paraherquamide A (57) in Penicillium fellutanum3,34 and α-cyclopiazonic acid (81) in Penicillium cyclopium.145,146 The results of these experiments showed clearly that tryptophan and dimethylallyl diphosphate (DMAPP) serve as biosynthetic precursors of indole or indoline and prenyl moieties of these compounds, respectively.3 The prenyl moieties are derived from the acetate–mevalonate pathway. Incorporation of tryptophan and mevalonolactone into the alkaloid molecules has been clearly demonstrated. Furthermore, additional precursors such as S-adenosylmethionine for methyl groups or a second amino acid for diketopiperazine derivatives were also proven by feeding experiments. In addition, enzyme activities for a number of biosynthetic reactions were demonstrated with crude extracts or partially purified protein fractions. Several excellent reviews have summarized the results of feeding experiments on prenylated indole alkaloids and enzymatic characterisation of certain reactions.1,3,34,111,147 This work will therefore not be repeated in this review.
It is worth mentioning the controversial discussion on the role of tryptophan as a biosynthetic precursor for indole-diterpenes.148 Feeding experiments in washed cells of a Nodulisporium mutant MF6244 showed clear incorporation of 2-13C-acetate and 2-13C-mevalonolactone into the indole-diterpene derivative nodulisporic acid A (95) and demonstrated the isoprene formation via the classical acetate–mevalonate pathway.142 Differing from the most prenylated indole alkaloids mentioned previously, the indole moiety of nodulisporic acid A (95) is most likely not derived from tryptophan, but from its precursor indole-3-glycerol phosphate (100). Incubations of Nodulisporium MF6244 with 14C- and 13C-tryptophan showed no incorporation of label into nodulisporic acid A (95). However, high levels of incorporation into nodulisporic acid A (95) were obtained with known tryptophan precursors such as 14C-, 13C-, and 15N-anthranilic acid as well as 14C- and 13C-ribose.142,148 These results are in contrast to those obtained for penitrem A (88) in Penicillium crustosum, which demonstrated a low incorporation of tryptophan into penitrem A (88).149
Significant progress has been achieved in the molecular biological and biochemical investigations on the biosynthesis of prenylated indole alkaloids in the last five years. In most cases, the biosynthetic genes were identified as a cluster in the genome sequences by bioinformatic approaches. Comparison of the orthologous geneclusters in different strains helps to identify a candidate gene for an enzymatic reaction, which can then be proven by molecular biological and biochemical characterisation.
3.2.1 Fumigaclavine biosynthesis in Aspergillus fumigatus. Fumigaclavine C (78) is an ergot alkaloid of the clavine-type and carries no peptidyl moiety, in comparison to ergopeptines from Claviceps purpurea.109 This compound is produced by Penicillium and Aspergillus strains, e.g. A. fumigatus,109 but not by the fungal family of the Clavicipitaceae, e.g. C. purpurea.109 Conversely, ergopeptines are produced by C. purpurea, but not by A. fumigatus.109 In contrast, chanoclavine-I (79) was identified in both fungal groups.109 Therefore, we have proposed that the early stages of the biosynthetic pathway of ergot alkaloids are very likely shared by A. fumigatus and C. purpurea, whereas later steps in the pathway differ in the two fungi.150 A genecluster for the biosynthesis of fumigaclavine C (78) (Fig. 2A) was identified on chromosome 2 of A. fumigatus Af293 and A1163 by bioinformatic approaches.9,151,152 This cluster consists probably of 11 putative genes and spans bp 2907012 to 2929163 of AAHF01000001 in Af293 (GenBank). Seven homologous genes were identified in both fumigaclavine clusters of A. fumigatus and the ergopeptine cluster of C. purpurea.9 The identification of the fumigaclavine cluster for a clavine-type ergot alkaloid lacking the peptidyl moiety provided a convenient way to identify candidate genes, which are involved in the common steps of the biosynthesis of ergot alkaloids by comparison of the two clusters in C. purpurea and A. fumigatus. Successful application of this strategy was clearly demonstrated by the identification of the dimethylallyltryptophan synthase FgaPT2151 and the N-methyltransferase FgaMT.150 FgaPT2 catalyses the first pathway-specific step of the ergot alkaloid biosynthesis, i.e. the C4-prenylation of L-tryptophan, resulting in formation of 4-dimethylallyl-L-tryptophan (4-DMAT (80)) (Scheme 1).151 The structure of FgaPT2 was recently solved with a resolution of 1.76 Å and showed significant similarity to bacterial prenyltransferases of the ABBA family,153 although no sequence similarity on the amino acid level could be detected for these enzymes.9,10 The availability of FgaPT2 structure provided a basis for understanding of the reaction mechanism of this important enzyme.153 FgaMT shared no significant sequence similarity with known proteins in databases and was found in both clusters, indicating its role in the early stage of the biosynthesis. By gene cloning and biochemical characterisation, it could be indeed shown that FgaMT catalysed the second step of the biosynthesis, i.e. the N-methylation of 4-DMAT (80), resulting in the formation of 4-DMA-L-abrine (101) (Scheme 1).150 Comparison of both geneclusters also helps to find candidate genes, which are involved in the later steps of the biosynthesis. This approach was demonstrated by the identification of the fumigaclavine B acetyltransferase FgaAT154 and fumigaclavine A prenyltransferase FgaPT1 in A. fumigatus.155 Both fgaAT and fgaPT1 were only found in the genecluster of fumigaclavine C in A. fumigatus, but not in C. purpurea.151 This finding corresponded well to the structural differences of the ergot alkaloids in the two strains, i.e. the presence of an acetoxyl and a reverse prenyl moiety in the structure of fumigaclavine C (78) and absence of these groups in ergopeptines. Biochemical investigations demonstrated that FgaAT catalyses the acetylation of fumigaclavine B (102) resulting in the formation of fumigaclavine A (103), which is then converted to fumigaclavine C (78) by FgaPT1 (Scheme 1).154,155
Scheme 1 Proposed biosynthetic pathway for fumigaclavine C in Aspergillus fumigatus.
Fig. 2 Biosynthetic geneclusters from different sources. A: fumigaclavine C cluster in Aspergillus fumigatus; B: fumitremorgin/verruculogen cluster in Aspergillus fumigatus; C: acetylaszonalenin cluster in Neosartorya fischeri; D: terrequinone A cluster in Aspergillus nidulans; E: α-cyclopiazonic acid cluster in Aspergillus flavus; F: paxilline cluster in Penicillium paxilli; G: lyngbyatoxin cluster in Lyngbya majuscula.
3.2.2 Fumitremorgin/verruculogen biosynthesis in Aspergillus fumigatus. From the genome sequence of Aspergillus fumigatus Af293, a cluster containing nine putative biosynthetic genes (Fig. 2B) was identified on chromosome 8 by using bioinformatic approaches.16 Homologous geneclusters could also be identified in the genome sequences of Aspergillus fumigatus A1163 and Neosartorya fischeri NRRL181, with sequence identities of the gene products between 82–100% to those of Af293.9 The end product of this cluster could be verruculogen (9),156 but it could not be excluded that fumitremorgin A (8) is the true end product instead. The fumitremorgin/verruculogen cluster was very likely not expressed in A. fumigatus Af293, therefore, no secondary metabolites of this cluster could be detected in this strain.157 In contrast, a number of intermediates including tryprostatins A (4) and B (2), fumitremorgin C (6), 12,13-dihydroxyfumitremorgin C (104), fumitremorgin B (7) as well as verruculogen (9) were isolated from A. fumigatus BM 939.158 The function of seven genes from this cluster was proven experimentally in recent years. The biosynthesis of fumitremorgin/verruculogen begins with the condensation of the two amino acidsL-tryptophan and L-proline catalysed by the nonribosomal peptide synthetase FtmPS (also termed FtmA) (Scheme 2). Expression of ftmPS in A. fumigatus resulted in the accumulation of the cyclic dipeptide brevianamide F (1),157 which is then converted to tryprostatin B (2) by the prenyltransferase FtmPT1/FtmB in the presence of dimethylallyl diphosphate.16 Conversion of tryprostatin B (2) to tryprostatin A (4) needs two steps, i.e.hydroxylation to 6-hydroxytryprostatin B (105) by the cytochrome P450 FtmP450-1/FtmC and methylation by the putative methyltransferase FtmMT/FtmD. The two other cytochrome P450s, i.e. FtmP450-2/FtmE and FtmP450-3/FtmG catalyse the conversion of tryprostatin A (4) to fumitremorgin C (6) by connection of the prenyl moiety to the diketopiperazine ring as well as fumitremorgin C (6) to 12,13-dihydroxyfumitremorgin C (104) by two hydroxylation steps, respectively (Scheme 2). The function of the three cytochrome P450 enzymes in the biosynthesis was proven by Kato et al.159 We have shown that the second prenyltransferase FtmPT2/FtmH in the cluster catalyses the conversion of 12,13-dihydroxyfumitremorgin C (104) to fumitremorgin B (7).160 Very recently, we have demonstrated that the non-heme Fe(II) and α-ketoglutarate-dependent dioxygenase FtmOx1/FtmF is involved in the formation of verruculogen (9) from fumitremorgin B (7).156 Kato et al.159 reported that ftmO (AFUA_8G00260) is likely not involved in the biosynthesis of fumitremorgin B (7) or verruculogen (9).
Scheme 2 Biosynthetic pathway for verruculogen or fumitremorgin A in Aspergillus fumigatus.
3.2.3 Acetylaszonalenin biosynthesis in Neosartorya fischeri. Acetylaszonalenin (37) is a mycotoxin carrying a reverse prenyl moiety at position C3 of the indoline ring and a fused ring between the indoline and the benzodiazepine ring system. Acetylaszonalenin (37) was isolated from a two week old culture of the genome reference strain Neosartorya fischeri NRRL181.68 Based on its structural feature, we hoped to find the biosynthetic genecluster in the genome sequence. Acetylaszonalenin (37) is chemically a cyclic dipeptide derivative of tryptophan and anthranilic acid, which is acetylated at position N1 and prenylated at position C3 of the indoline ring. It could be expected that at least three genes/enzymes are involved in the biosynthesis of acetylaszonalenin (37), i.e. a nonribosomal peptide synthethase for the formation of the cyclic dipeptide,157,161 a prenyltransferase for a prenyl transfer162 and an acetyltransferase for an acetyl transfer reaction. The formation of the fused ring between the indoline and the benzodiazepine ring system would require an additional enzyme or would be catalysed during the prenylation by the prenyltransferase. Indeed, a 12.8 kb DNA segment consisting of three genes and spanning bp 130585–143349 of AAKE03000024.1 was identified in N. fischeri NRRL181 by homologous search and sequence analysis (Fig. 2C). An orthologous cluster was also identified in the genome sequence of Aspergillus terreus NIH2624.68 The putative genesanaPS, anaPT and anaAT in this cluster coding for the three putative enzymes mentioned above are likely involved in the biosynthesis of acetylaszonalenin (37).68AnaPS is predicted to encode a dimodular nonribosomal peptide synthetase (NRPS) with two adenylation domains (A), two peptidyl carrier domains (P) and two condensation domains (C), which is expected to be responsible for the condensation of the amino acids tryptophan and anthranilic acid (Scheme 3). AnaPT showed clear sequence similarity to indole prenyltransferases and was proven to be responsible for the reverse C3-prenylation of (R)-benzodiazopindinone (106) in the presence of DMAPP, resulting in formation of aszonalenin (38).68 These results provided evidence that AnaPT catalyses both the prenyl transfer reaction and the cyclisation between the indoline and the benzodiazepine ring system. By gene cloning and biochemical characterization of the recombinant gene product, it was shown that AnaAT catalyses the acetylation of aszonalenin (38), resulting in the formation of acetylaszonalenin (37) (Scheme 3).68 The biosynthetic pathway described for acetylaszonalenin (37) could also be plausible for other dipeptide derivatives with prenyl moieties at position C3 of the indoline rings, e.g. roquerfortine C (31), amauromines (24, 25), fructigenines (41, 53) and brevicompanine (54).62,68,87 This includes the formation of cyclic dipeptides with a diketopiperazine structure catalysed by NRPS, prenylation and cyclisation catalysed by a prenyltransferase, and acetylation (if necessary) by an acetyltransferase.
Scheme 3 Biosynthetic pathway for acetylaszonalenin in Neosartorya fischeri.
3.2.4 Terrequinone A biosynthesis in Aspergillus nidulans. A cluster consisting of five genes for the biosynthesis of terrequinone A (71) (Fig. 2D) was identified in Aspergillus nidulans during a genome-wide survey for active natural productgenes.103 All five genestdiA–tdiE could be characterised by heterologous overexpression.163 TdiD is a pyridoxal-5-phosphate-dependent L-tryptophan aminotransferase that generates indole pyruvate (107) for an unusual non-oxidative coupling by the tridomain nonribosomal peptide synthetase TdiA, resulting in the formation of the quinone derivative didemethylasterriquinone D (108) (Scheme 4),163 which is then converted to asterriquinone C-1 (110) by the prenyltransferase TdiB.164 TdiC, an NADH-dependent quinone reductase catalyses the reduction of didemethylasterriquinone D (108) to the nucleophilic hydroquinone (109), which is converted to the end product of the cluster terrequinone A (71) by TdiB in the presence of TdiE (Scheme 4).163
Scheme 4 Biosynthetic pathway for terrequinone A in Aspergillus nidulans.
3.2.5 α-Cyclopiazonic acid biosynthesis in Aspergillus oryzae and A. flavus. A genecluster for the biosynthesis of α-cyclopiazonic acid consisting of three genes (Fig. 2E) was identified in the genome sequences of Aspergillus oryzae and Aspergillus flavus.165–168 The hybrid two-module polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) CpaS (termed also CpaA) is responsible for the formation of the tetramic acid cyclo-acetoacetyl-L-tryptophan (cAATrp) (111) (Scheme 5), which was proven by gene disruption165,166 and by functional expression.167,168 cAATrp (111) should be then prenylated by the putative prenyltransferase CpaD, resulting in the formation of β-cyclopiazonic acid (112). The conversion of β- to α-cyclopiazonic acid (81) would be catalysed by the putative monoamine oxidase CpaO (Scheme 5). Disruption of both genes in Aspergillus flavus, termed dmaT and maoA, respectively, abolished the cyclopiazonic acid production and demonstrated their involvement in the biosynthesis.166
Scheme 5 Proposed biosynthetic pathway for α-cyclopiazonic acid in Aspergillus flavus and Aspergillus oryzae.
3.2.6 Indole-diterpene biosynthesis in Penicillium, Neotyphodium and Epichloë. Paspaline (113) is proposed to be the first stable indole-diterpene intermediate from which many other metabolites of this class are derived.11 The structural diversity observed within this group of metabolites is achieved by additional prenylations, different ring substitution patterns and stereochemistry.2 Considerable progress has been achieved in recent years on understanding indole-diterpene biosynthesis in filamentous fungi.11 A cluster consisting of seven genes (Fig. 2F) necessary for the biosynthesis of paxilline (114) was identified in Penicillium paxilli.169 By gene deletion and complementation as well as by feeding experiments with proposed precursors, it has been shown that four gene products, i.e. a geranylgeranyl diphosphate synthase PaxG, a FAD-dependent monooxygenase PaxM, a prenyltransferase PaxC and a membrane-associated protein PaxB are required for the formation of paspaline from indole-3-glycerol phosphate (100),11,170 which is converted to desoxypaxilline (115) by a cytochrome P450 monooxygenase PaxP and then to paxilline (114) by a cytochrome P450monooxygenase PaxQ (Scheme 6).171 Orthologous geneclusters (ltmcluster) were also found in lolitrem producers Neotyphodium lolii and Epichloë festucae.11,172,173 Two additional genes, ltmE and ltmJ, coding for a putative prenyltransferase and a cytochrome P450enzyme, respectively, were also identified in these fungi172 and proposed to be involved in the conversion of desoxypaxilline (115) to lolitrems (90, 91).174
Scheme 6 Proposed biosynthetic pathway for paxilline in Penicillium paxilli.
A genecluster containing homologues of paxG, paxM, and paxC, designated atmG, atmM, and atmC, respectively, was also identified in the aflatrem producer Aspergillus flavus NRRL 6541.175 Analysis of the genome sequences of A. flavus NRRL 3357 and Aspergillus oryzae RIB40 has revealed the presence of an aflatrem cluster similar to that of A. flavus NRRL 6541 mentioned above.11 These genomes also contain a second genecluster at a separate chromosomal locus, which includes homologues of paxP, paxQ, paxA, paxB, and paxD.11 Thus, homologues of all seven genes necessary for paxilline (114) production in Penicillium paxilli are present in the genomes of A. flavus and A. oryzae, supporting the proposal that aflatrem production proceeds via paspaline (113) and paxilline (114) intermediates.11
4 Production of prenylated indole derivatives by chemoenzymatic synthesis
As discussed under section 2, many prenylated alkaloids are derived from the same amino acids. For example, tryprostatins (2, 4), fumitremorgins (6–8), brevianamides (10, 15), notoamides (12–14) and stephacidins (16, 19) are derivatives of cyclo-L-Trp-L-Pro. Cyclo-L-Trp-L-Trp is the common precursor of fellutanines (20–22), amauromines (24, 25) and okaramines (26–29). They differ from each other in prenylation position and manner (regular or reverse) as well as by further modifications. It can be expected that the respective cyclic dipeptide is formed by similar nonribosomal peptide synthetases in different producers, but diverse prenyltransferases contribute significantly to the large structure diversity within the prenylated indole alkaloids. The same conclusion is also applicable for asterriquinones and related compounds (61–71), which distinguish from each other by number and position of the prenyl moieties at the indole rings. Therefore, prenyl transfer reactions catalysed by prenyltransferases represent key steps in the biosynthesis of natural products. For this reason, prenyltransferases from different sources are important research topics in the field of secondary metabolism.9,176
In recent years, ten indole prenyltransferase genes from various fungi were cloned and overexpressed in Escherichia coli or Saccharomyces cerevisiae.10,12 The overproduced proteins were proven to be soluble proteins and could be purified to near homogeneity by affinity chromatography in good yields.9 These prenyltransferases catalyse diverse prenyl transfer reactions onto different indole positions of various substrates.9,10 Investigations on substrate specificity of the characterised indole prenyltransferases revealed that these enzymes were specific for DMAPP as prenyl donor. Product formation was only observed with DMAPP, but not with geranyl diphosphate under the tested conditions.16,68,151,155,160,177,178 In contrast, they showed notable substrate flexibility towards their aromatic substrates.16,162,177–179 Diverse simple tryptophan derivatives (116) and tryptophan-containing cyclic dipeptides (117) were accepted by several prenyltransferases as substrates and converted to prenylated derivatives. For example, the two dimethylallyltryptophan synthases FgaPT2 and 7-DMATS, which catalyse the regular prenylation at positions C4 and C7 of the indole ring of L-tryptophan, respectively, accepted a series of simple tryptophan derivatives (116) with modifications at the side chain and at the indolenucleus as substrates.179,180 Notably, they also accepted tryptophan-containing cyclic dipeptides (117) as aromatic substrates.181 Conversely, the cyclic dipeptide prenyltransferases FtmPT1 and CdpNPT accepted not only tryptophan-containing cyclic dipeptides (117),16,162 but also simple indole derivatives (116) as substrates.182 More importantly, the prenyl transfer reactions catalysed by indole prenyltransferases are highly regiospecific.9,12 These features of substrate flexibility and reaction regiospecificity were successfully used for production of prenylated indole derivatives.12
By using chemoenzymatic synthesis with purified enzymes, it was possible to obtain three monoprenylated products from one simple indole derivative (116). The prenyltransferases FtmPT1 or CdpNPT, FgaPT2, and 7-DMATS converted the same substrate to derivatives with a prenyl moiety at position N1 (118), C4 (119) or C7 (120) of the indole ring, respectively (Scheme 7)179,180,182 By a tandem incubation with FgaPT2 and 7-DMATS, 4,7-diprenylated indole derivatives (121) have also been produced (Scheme 7).183
Scheme 7 Chemoenzymatic synthesis of prenylated simple indole derivatives.
By using the same strategy, at least five derivatives with prenyl moieties at N1 (122), C2 (123), C3 (124), C4 (125) and C7 (126) could be obtained from one tryptophan-containing cyclic dipeptide (Scheme 8). CdpNPT prenylates these compounds at position N1 of the indole ring, resulting in the formation of reversely prenylated derivatives (122).162 FtmPT1 is able to prenylate tryptophan-containing cyclic dipeptides at position C2 of the indole moiety.16,184 C3, C4 and C7-prenylated derivatives (124–126) could be obtained by using AnaPT, FgaPT2 or 7-DMATS, respectively.181 (Yin and Li, Kremer and Li, unpublished results)
Scheme 8 Chemoenzymatic synthesis of prenylated cyclic dipeptides.
Prenylated indole alkaloids are mainly, but not exclusively, found in fungi. They exist also in other domains of life such as bacteria, especially in actinomycetes and cyanobacteria, plants, as well as bryozoans.
Lyngbyatoxin A (127) from the cyanobacterium Lyngbya majuscula is a derivative of indolactam-V (128), a cyclic dipeptide consisting of L-valine and L-tryptophan, which is connected via its C7 to a geranyl moiety.185 Derivatives of indolactam-V (128) such as the tumour promoters teleocidin B-4 (129), olivoretin A (130) and blastmycetin E (131) were identified in various actinomycetes such as Streptomyces mediocidicus, Streptoverticillium olivoreticuli and Streptoverticillium blastmycetium.186–190
The biosynthesis of lyngbyatoxin A (127) was extensively studied by identification of a biosynthetic genecluster191 and by biochemical investigation with an overproduced enzyme.192 The genecluster (Fig. 2G) consists of four genesltxABCD, which encode for a nonribosomal peptide synthetase, a cytochrome P450 monooxygenase, a prenyltransferase and an oxidoreductase, respectively.191 LtxA, containing additional N-methylation and reduction domains, catalyses the condensation of the amino acidsL-valine and L-tryptophan, resulting in the formation of the linear dipeptide (132), which is then cyclised by LtxB to (−)-indolactam-V (128) (Scheme 9). Conversion of (−)-indolactam (128) to lyngbyatoxin A (127) would be catalysed by LtxC. LtxD would convert lyngbyatoxin A (127) to lyngbyatoxin B (133) (Scheme 9).191,192 In contrast, little is known about the biosynthesis of teleocidins, olivoretins or blastmycetins in actinomyces on the molecular biological and biochemical level.
Scheme 9 Proposed biosynthetic pathway for lynbyatoxins in Lynbya majuscula.
From the cyanobacterium Fischerella sp., nine antimicrobial isonitrile-containing indole alkaloids were isolated.193 These compounds, like ambiguine H isonitrile (134) and ambiguine F isonitrile (135), can be considered as tryptophan derivatives, which are connected to a reverse dimethylallyl and geranyl moiety at positions C2 and C4, respectively. Monoprenylated derivatives like 12-epi-hapalindole H (136) have also been reported.193
A number of simple prenylated indole derivatives were identified in the bryozoan Flustra foliacea.194–196 They are often brominated tryptamine derivatives with prenyl moieties at different positions of the indole ring like flustramines A (137), C (138) and D (139).197,198
Prenylated indole derivatives occur also in higher plants. A large number of carbazole alkaloids have been isolated from higher plants of the genera Murraya, Glycosmis and Clausena, all belonging to the family Rutaceae.199 Two examples are mahanimbine (140) and biskoenigine (141) from Murraya koenigii.200,201
6 Conclusions
A large number of prenylated indole alkaloids with various structural features and important pharmacological activities have been identified in different sources, especially in filamentous fungi. Investigations on their biosynthesis in the last century have been mainly limited to feeding experiments with precursors and biochemical characterisation with crude extracts or partially purified enzymes from producers.3,111 Molecular biological and biochemical research with structural genes began ten years ago,202 but significant progress was achieved only after sequence release of genome sequencing projects for fungal strains, especially for Aspergillus strains in 2003/2004. The availability of more and more genome sequences provides an enormous chance for the study of secondary metabolites. Meanwhile, this is also a challenge for natural product research. Numerous genes and geneclusters with unknown functions have been identified in genome sequences,203 and functional proof of these genes and identification of the natural products coded by the geneclusters will be the main challenges for natural product chemists and biologists in the coming years or even decades. Therefore, it can be expected that more and more designed biologically-active substances will be produced by genetic manipulation.
7 Acknowledgements
The work in the author's laboratory was supported by grants from the Deutsche Forschungsgemeinschaft.
8 References
C. L. Schardl, D. G. Panaccione and P. Tudzynski, Alkaloids: Chem. Biol., 2006, 63, 45–86 Search PubMed.
H. Sings and S. Singh, Alkaloids: Chem. Biol., 2003, 60, 51–163 Search PubMed.
R. M. Williams, E. M. Stocking and J. F. Sanz-Cervera, Top. Curr. Chem., 2000, 209, 97–173 CAS.
M. G. Jones, Microbiology, 2007, 153, 1–6 CrossRefCAS.
D. M. Raskin, R. Seshadri, S. U. Pukatzki and J. J. Mekalanos, Cell, 2006, 124, 703–714 CrossRefCAS.
B. Wilkinson and J. Micklefield, Nat. Chem. Biol., 2007, 3, 379–386 CrossRefCAS.
M. Zerikly and G. L. Challis, ChemBioChem, 2009, 10, 625–633 CrossRefCAS.
C. Corre and G. L. Challis, Nat. Prod. Rep., 2009, 26, 977–986 RSC.
N. Steffan, A. Grundmann, W.-B. Yin, A. Kremer and S.-M. Li, Curr. Med. Chem., 2009, 16, 218–231 CrossRefCAS.
K. Higuchi and T. Kawasaki, Nat. Prod. Rep., 2007, 24, 843–868 RSC.
M. Toyota and M. Ihara, Nat. Prod. Rep., 1998, 15, 327–340 RSC.
K. Arai and Y. Yamamoto, Chem. Pharm. Bull., 1990, 38, 2929–2932 CAS.
A. Grundmann and S.-M. Li, Microbiology, 2005, 151, 2199–2207 CrossRefCAS.
H. Kato, T. Yoshida, T. Tokue, Y. Nojiri, H. Hirota, T. Ohta, R. M. Williams and S. Tsukamoto, Angew. Chem., Int. Ed., 2007, 46, 2254–2256 CrossRefCAS.
S. Tsukamoto, H. Kato, M. Samizo, Y. Nojiri, H. Onuki, H. Hirota and T. Ohta, J. Nat. Prod., 2008, 71, 2064–2067 CrossRefCAS.
M. Yamazaki, K. Sasago and K. Miyaki, J. Chem. Soc., Chem. Commun., 1974, 408–409 RSC.
M. Yamazaki and S. Suzuki, Dev. Toxicol. Environ. Sci., 1986, 12, 273–282 Search PubMed.
R. T. Gallagher and G. C. M. Latch, Appl. Environ. Microbiol., 1977, 33, 730–731 CAS.
M. Sabater-Vilar, S. Nijmeijer and J. Fink-Gremmels, J. Food Prot., 2003, 66, 2123–2129 CAS.
I. Kosalec, M. S. Klaric and S. Pepeljnjak, Acta Pharm., 2005, 55, 357–364 CAS.
K. Khoufache, O. Puel, N. Loiseau, M. Delaforge, D. Rivollet, A. Coste, C. Cordonnier, E. Escudier, F. Botterel and S. Bretagne, BMC Microbiol., 2007, 7, 5 CrossRef.
M. Yamazaki, H. Fujimoto and T. Kawasaki, Tetrahedron Lett., 1975, 16, 1241–1244 CrossRef.
C. B. Cui, H. Kakeya, G. Okada, R. Onose, M. Ubukata, I. Takahashi, K. Isono and H. Osada, J. Antibiot., 1995, 48, 1382–1384 CAS.
M. Kondoh, T. Usui, T. Mayumi and H. Osada, J. Antibiot., 1998, 51, 801–804 CAS.
S. Zhao, K. S. Smith, A. M. Deveau, C. M. Dieckhaus, M. A. Johnson, T. L. Macdonald and J. M. Cook, J. Med. Chem., 2002, 45, 1559–1562 CrossRefCAS.
S. K. Rabindran, D. D. Ross, L. A. Doyle, W. Yang and L. M. Greenberger, Cancer Res., 2000, 60, 47–50 CAS.
J. D. Allen, A. van Loevezijn, J. M. Lakhai, d. van, V, O. van Tellingen, G. Reid, J. H. Schellens, G. J. Koomen and A. H. Schinkel, Mol. Cancer Ther., 2002, 1, 417–425 CAS.
S. K. Rabindran, H. He, M. Singh, E. Brown, K. I. Collins, T. Annable and L. M. Greenberger, Cancer Res., 1998, 58, 5850–5858 CAS.
H. D. Jain, C. Zhang, S. Zhou, H. Zhou, J. Ma, X. Liu, X. Liao, A. M. Deveau, C. M. Dieckhaus, M. A. Johnson, K. S. Smith, T. L. Macdonald, H. Kakeya, H. Osada and J. M. Cook, Bioorg. Med. Chem., 2008, 16, 4626–4651 CrossRefCAS.
H. Woehlecke, H. Osada, A. Herrmann and H. Lage, Int. J. Cancer, 2003, 107, 721–728 CrossRefCAS.
R. M. Williams and R. J. Cox, Acc. Chem. Res., 2003, 36, 127–139 CrossRefCAS.
A. J. Birch and J. J. Wright, J. Chem. Soc. D, 1969, 644b–645 RSC.
P. S. Steyn, Tetrahedron, 1973, 29, 107–120 CrossRefCAS.
G.-Y. Li, T. Yang, Y.-G. Luo, X.-Z. Chen, D. M. Fang and G.-L. Zhang, Org. Lett., 2009, 11, 3714–3717 CrossRefCAS.
S. Tsukamoto, T. Kawabata, H. Kato, T. J. Greshock, H. Hirota, T. Ohta and R. M. Williams, Org. Lett., 2009, 11, 1297–1300 CrossRefCAS.
J. Qian-Cutrone, S. Huang, Y. Z. Shu, D. Vyas, C. Fairchild, A. Menendez, K. Krampitz, R. Dalterio, S. E. Klohr and Q. Gao, J. Am. Chem. Soc., 2002, 124, 14556–14557 CrossRefCAS.
T. J. Greshock, A. W. Grubbs, S. Tsukamoto and R. M. Williams, Angew. Chem., Int. Ed., 2007, 46, 2262–2265 CrossRef.
A. G. Kozlovsky, N. G. Vinokurova, V. M. Adanin, G. Burkhardt, H. M. Dahse and U. Gräfe, J. Nat. Prod., 2000, 63, 698–700 CrossRefCAS.
B. Nuber, F. Hansske, C. Shinohara, S. Miura, K. Hasumi and A. Endo, J. Antibiot., 1994, 47, 168–172 CAS.
S. Takase, Y. Kawai, I. Uchida, H. Tanaka and H. Aoki, Tetrahedron, 1985, 41, 3037–3048 CrossRefCAS.
F. S. De Guzman and J. B. Glober, J. Nat. Prod., 1992, 55, 931–939 CrossRefCAS.
H. Hayashi, K. Takiuchi, S. Murao and M. Arai, Agric. Biol. Chem., 1989, 53, 461–469 CAS.
H. Hayashi, Y. Asabu, S. Murao and M. Arai, Biosci., Biotechnol., Biochem., 1995, 59, 246–250 CrossRefCAS.
H. Hayashi, K. Furutsuka and Y. Shiono, J. Nat. Prod., 1999, 62, 315–317 CrossRefCAS.
Y. Shiono, K. Akiyama and H. Hayashi, Biosci., Biotechnol., Biochem., 1999, 63, 1910–1920 CAS.
Y. Shiono, K. Akiyama and H. Hayashi, Biosci., Biotechnol., Biochem., 2000, 64, 103–110 CAS.
C. Shinohara, K. Hasumi, Y. Takei and A. Endo, J. Antibiot., 1994, 47, 163–167 CAS.
S. Takase, Y. Kawai, I. Uchida, H. Tanaka and H. Aoki, Tetrahedron Lett., 1984, 25, 4673–4676 CrossRefCAS.
H. Hayashi, Foods Food Ingredients J. Jpn., 2008, 213, 1079–1085 Search PubMed.
P. M. Scott and B. P. C. Kennedy, J. Agric. Food Chem., 1976, 24, 865–868 CrossRefCAS.
T. Rundberget, I. Skaar and A. Flaoyen, Int. J. Food Microbiol., 2004, 90, 181–188 CrossRefCAS.
C. Finoli, A. Vecchio, A. Galli and I. Dragoni, J. Food Prot., 2001, 64, 246–251 CAS.
M. O'Brien, K. F. Nielsen, P. O'Kiely, P. D. Forristal, H. T. Fuller and J. C. Frisvad, J. Agric. Food Chem., 2006, 54, 9268–9276 CrossRefCAS.
J. C. Frisvad, J. Smedsgaard, T. O. Larsen and R. A. Samson, Stud. Mycol., 2004, 49, 201–241 Search PubMed.
T. A. Reshetilova, N. G. Vinokurova, V. N. Khmelenina and A. G. Kozlovskii, Microbiology (Moscow), 1995, 64, 27–29 Search PubMed.
P. S. Steyn and R. Vleggaar, J. Chem. Soc., Chem. Commun., 1983, 560–561 RSC.
D. P. Overy, K. F. Nielsen and J. Smedsgaard, J. Chem. Ecol., 2005, 31, 2373–2390 CrossRefCAS.
B. Clark, R. J. Capon, E. Lacey, S. Tennant and J. H. Gill, J. Nat. Prod., 2005, 68, 1661–1664 CrossRefCAS.
L. Du, D. Li, T. Zhu, S. Cai, F. Wang, X. Xiao and Q. Gu, Tetrahedron, 2009, 65, 1033–1039 CrossRefCAS.
G. A. Ellestad, P. Mirando and M. P. Kunstmann, J. Org. Chem., 1973, 38, 4204–4205 CrossRefCAS.
Y. Kimura, T. Hamasaki, H. Nakajima and A. Isogai, Tetrahedron Lett., 1982, 23, 225–228 CrossRef.
A. Hayashi, S. Fujioka, M. Nukina, T. Kawano, A. Shimada and Y. Kimura, Biosci., Biotechnol., Biochem., 2007, 71, 1697–1702 CrossRefCAS.
R. J. Capon, C. Skene, M. Stewart, J. Ford, R. A. J. O'Hair, L. Williams, E. Lacey, J. H. Gill, K. Heiland and T. Friedel, Org. Biomol. Chem., 2003, 1, 1856–1862 RSC.
D. Wakana, T. Hosoe, T. Itabashi, K. Nozawa, K. Okada, G. M. d. C. Takaki, T. Yaguchi, K. Fukushima and K. I. Kawai, Mycotoxins, 2006, 56, 3–6 CrossRefCAS.
W.-B. Yin, A. Grundmann, J. Cheng and S.-M. Li, J. Biol. Chem., 2009, 284, 100–109 CAS.
C. Rank, R. K. Phipps, P. Harris, J. C. Frisvad, C. H. Gotfredsen and T. O. Larsen, Tetrahedron Lett., 2006, 47, 6099–6102 CrossRefCAS.
K. Arai, K. Kimura, T. Mushiroda and Y. Yamamoto, Chem. Pharm. Bull., 1989, 37, 2937–2939 CAS.
A. G. Kozlovsky, V. M. Adanin, H. M. Dahse and U. Gräfe, Appl. Biochem. Microbiol., 2001, 37, 253–256 Search PubMed.
A. J. Birch, G. E. Blance, S. David and H. Smith, J. Chem. Soc., 1961, 3128–3131 RSC.
R. D. Stipanovic and H. W. Schroeder, Trans. Br. Mycol. Soc., 1976, 66, 178–179 Search PubMed.
W. L. Wang, Z. Y. Lu, H. W. Tao, T. J. Zhu, Y. C. Fang, Q. Q. Gu and W. M. Zhu, J. Nat. Prod., 2007, 70, 1558–1564 CrossRefCAS.
Y. Li, X. Li, J. S. Kang, H. D. Choi and B. W. Son, J. Antibiot., 2004, 57, 337–340 CAS.
G. J. Slack, E. Puniani, J. C. Frisvad, R. A. Samson and J. D. Miller, Mycol. Res., 2009, 113, 480–490 Search PubMed.
W. Zhao, Y. Guo, Y. Tezuka and T. Kikuchi, Zhongguo Zhongyao Zazhi, 1991, 16, 425–426 Search PubMed.
S. K. Talapatra, S. K. Mandal, A. Bhaumik, S. Mukhopadhyay, P. Kar, A. Patra and B. Talapatra, J. Indian Chem. Soc., 2001, 78, 773–777 CAS.
T. Itabashi, N. Matsuishi, T. Hosoe, N. Toyazaki, S. Udagawa, T. Imai, M. Adachi and K. Kawai, Chem. Pharm. Bull., 2006, 54, 1639–1641 CrossRefCAS.
Y. Wang, J. B. Gloer, J. A. Scott and D. Malloch, J. Nat. Prod., 1995, 58, 93–99 CrossRefCAS.
H. Fujimoto, T. Fujimaki, E. Okuyama and M. Yamazaki, Chem. Pharm. Bull., 1999, 47, 1426–1432 CAS.
L. K. Hansen, F. C. Størmer, D. Petersen and A. J. Aasen, Acta Crystallogr., Sect. E: Struct. Rep. Online, 2001, 57, o909–o912 CrossRef.
K. Arai, S. Sato, S. Shimizu, K. Nitta and Y. Yamamoto, Chem. Pharm. Bull., 1981, 29, 1510–1517 CAS.
J. E. Hochlowski, M. M. Mullally, S. G. Spanton, D. N. Whittern, P. Hill and J. B. McAlpine, J. Antibiot., 1993, 46, 380–386 CAS.
W. L. Wang, T. J. Zhu, H. W. Tao, Z. Y. Lu, Y. C. Fang, Q. Q. Gu and W. M. Zhu, Chem. Biodiversity, 2007, 4, 2913–2919 CrossRefCAS.
R. P. Hodge, C. M. Harris and T. M. Harris, J. Nat. Prod., 1988, 51, 66–73 CrossRefCAS.
L. Du, X. Yang, T. Zhu, F. Wang, X. Xiao, H. Park and Q. Gu, Chem. Pharm. Bull., 2009, 57, 873–876 CrossRefCAS.
J. G. Ondeyka, A. W. Dombrowski, J. P. Polishook, T. Felcetto, W. L. Shoop, Z. Guan and S. B. Singh, J. Ind. Microbiol. Biotechnol., 2003, 30, 220–224 CAS.
T. Kagamizono, N. Sakai, K. Arai, K. Kobinata and H. Osada, Tetrahedron Lett., 1997, 38, 1223–1226 CrossRefCAS.
Y. Yamamoto, K. Nishimura and N. Kiriyama, Chem. Pharm. Bull., 1976, 24, 1853–1859 CAS.
Y. Yamamoto, N. Kiriyama, S. Shimizu and S. Koshimura, Gann, 1976, 67, 623–624 CAS.
K. Arai, K. Masuda, N. Kiriyama, K. Nitta, Y. Yamamoto and S. Shimizu, Chem. Pharm. Bull., 1981, 29, 961–969.
K. Arai, S. Shimizu and Y. Yamamoto, Chem. Pharm. Bull., 1981, 29, 1005–1012 CAS.
A. Kaji, T. Iwata, N. Kiriyama, S. Wakusawa and K. Miyamoto, Chem. Pharm. Bull., 1994, 42, 1682–1684 CAS.
S. Sekita, Chem. Pharm. Bull., 1983, 31, 2998–3001 CAS.
M. A. O'Leary and J. R. Hansen, Tetrahedron Lett., 1982, 23, 1855–1856 CrossRefCAS.
J. He, E. M. K. Wijeratne, B. P. Bashyal, J. Zhan, C. J. Seliga, M. X. Liu, E. E. Pierson, L. S. Pierson, H. D. VanEtten and A. A. L. Gunatilaka, J. Nat. Prod., 2004, 67, 1985–1991 CrossRefCAS.
M. Ooike, K. Nozawa, S. Udagawa and K. Kawai, Chem. Pharm. Bull., 1997, 45, 1694–1696 CAS.
U. Mocek, L. Schultz, T. Buchan, C. Baek, L. Fretto, J. Nzerem, L. Sehl and U. Sinha, J. Antibiot., 1996, 49, 854–859 CAS.
A. Fredenhagen, F. Petersen, M. Tintelnot-Blomley, J. Rosel, H. Mett and P. Hug, J. Antibiot., 1997, 50, 395–401 CAS.
M. A. O'Leary, J. R. Hanson and B. L. Yeoh, J. Chem. Soc., Perkin Trans. 1, 1984, 567–569 RSC.
F. S. De Guzman, D. R. Bruss, J. M. Rippentrop, K. B. Gloer and J. B. Gloer, J. Nat. Prod., 1994, 57, 634–639 CrossRefCAS.
J. W. Bok, D. Hoffmeister, L. A. Maggio-Hall, R. Murillo, J. D. Glasner and N. P. Keller, Chem. Biol., 2006, 13, 31–37 CrossRefCAS.
A. Kaji, R. Saito, M. Nomura, K. Miyamoto and N. Kiriyama, Anticancer Res., 1997, 17, 3675–3679 CAS.
A. Kaji, R. Saito, M. Nomura, K. Miyamoto and N. Kiriyama, Biol. Pharm. Bull., 1998, 21, 945–949 CAS.
A. Kaji, T. Iwata, N. Kiriyama, M. Nomura and K. Miyamoto, J. Antibiot., 1998, 51, 235–238 CAS.
A. Kaji, K. Kimura, M. Teranishi, N. Kiriyama, M. Nomura and K. Miyamoto, Chem. Pharm. Bull., 1998, 46, 1325–1329 CAS.
S. B. Singh, J. G. Ondeyka, N. Tsipouras, C. Ruby, V. Sardana, M. Schulman, M. Sanchez, F. Pelaez, M. W. Stahlhut, S. Munshi, D. B. Olsen and R. B. Lingham, Biochem. Biophys. Res. Commun., 2004, 324, 108–113 CrossRefCAS.
M. Flieger, M. Wurst and R. Shelby, Folia Microbiol., 1997, 42, 3–30 Search PubMed.
T. Haarmann, Y. Rolke, S. Giesbert and P. Tudzynski, Mol. Plant Pathol., 2009, 10, 563–577 CrossRefCAS.
D. Gröger and H. G. Floss, Alkaloids: Chem. Biol., 1998, 50, 171–218 Search PubMed.
R. Krska and C. Crews, Food Addit. Contam., Part A, 2008, 25, 722–731 Search PubMed.
P. Tudzynski, T. Correia and U. Keller, Appl. Microbiol. Biotechnol., 2001, 57, 593–605 CrossRefCAS.
K. Moncoq, C. A. Trieber and H. S. Young, J. Biol. Chem., 2007, 282, 9748–9757 CrossRefCAS.
C. W. Holzapfel, R. D. Hutchison and D. C. Wilkins, Tetrahedron, 1970, 26, 5239–5246 CrossRefCAS.
N. G. Vinokurova, N. E. Ivanushkina, I. I. Khmel'nitskaia and M. U. Arinbasarov, Appl. Biochem. Microbiol., 2007, 43, 435–438 Search PubMed.
C. Finoli, A. Vecchio, A. Galli and L. Franzetti, J. Food Prot., 1999, 62, 1198–1202 CAS.
K. Hermansen, J. C. Frisvad, C. Emborg and J. Hansen, FEMS Microbiol. Lett., 1984, 21, 253–261 CrossRefCAS.
F. Nunez, C. D. Westphal, E. Bermudez and M. A. Asensio, J. Food Prot., 2007, 70, 2829–2836 CAS.
A. S. Moldes-Anaya, T. N. Asp, G. S. Eriksen, I. Skaar and T. Rundberget, J. Chromatogr., A, 2009, 1216, 3812–3818 CrossRefCAS.
M. Abe, S. Ohmomo, T. Ohashi and T. Tabuchi, Agric. Biol. Chem., 1969, 33, 469–471 CAS.
R. J. Cole, J. W. Kirksey, S. M. Weinreb, P. Singh, D. Kim, J. Clardy and N. Eickman, Tetrahedron Lett., 1976, 17, 3849–3852 CrossRef.
J. W. Dorner, R. J. Cole, R. Hill, D. Wicklow and R. H. Cox, Appl. Environ. Microbiol., 1980, 40, 685–687 CAS.
R. J. Cole, J. W. Dorner, J. A. Lansden, R. H. Cox, C. Pape, B. Cunfer, S. S. Nicholson and D. M. Bedell, J. Agric. Food Chem., 1977, 25, 1197–1201 CrossRefCAS.
R. J. Cole, J. W. Dorner, J. P. Springer and R. H. Cox, J. Agric. Food Chem., 1981, 29, 293–295 CrossRefCAS.
R. T. Gallagher and B. J. Wilson, Mycopathologia, 1979, 66, 183–185 CrossRefCAS.
R. E. Wagener, N. D. Davis and U. L. Diener, Appl. Environ. Microbiol., 1980, 39, 882–887 CAS.
J. L. Richard and L. H. Arp, Mycopathologia, 1979, 67, 107–109 CAS.
A. Ciegler, Mycopathologia, 1978, 65, 5–11 CrossRefCAS.
T. Rundberget, I. Skaar, O. O'Brien and A. Flåoyen, Mycopathologia, 2004, 157, 349–357 CrossRef.
A. E. De Jesus, P. S. Steyn, F.
R. van Heerden, R. Vleggaar, P. L. Wessels and W. E. Hull, J. Chem. Soc., Chem. Commun., 1981, 289–291 RSC.
R. T. Gallagher, E. P. White and P. H. Mortimer, N. Z. Vet. J., 1981, 29, 189–190 Search PubMed.
R. X. Tan and W. X. Zou, Nat. Prod. Rep., 2001, 18, 448–459 RSC.
O. F. Smetanina, A. I. Kalinovsky, Y. V. Khudyakova, M. V. Pivkin, P. S. Dmitrenok, S. N. Fedorov, H. Ji, J. Y. Kwak and T. A. Kuznetsova, J. Nat. Prod., 2007, 70, 906–909 CrossRefCAS.
M. Xu, G. Gessner, I. Groth, C. Lange, A. Christner, T. Bruhn, Z. Deng, X. Li, S. H. Heinemann, S. Grabley, G. Bringmann, I. Sattler and W. Lin, Tetrahedron, 2007, 63, 435–444 CrossRefCAS.
T. Hosoe, T. Itabashi, N. Kobayashi, S. I. Udagawa and K. I. Kawai, Chem. Pharm. Bull., 2006, 54, 185–187 CrossRefCAS.
J. G. Ondeyka, G. L. Helms, O. D. Hensens, M. A. Goetz, D. L. Zink, A. Tsipouras, W. L. Shoop, L. Slayton, A. W. Dombrowski, J. D. Polishook, D. A. Ostlind, N. N. Tsou, R. G. Ball and S. B. Singh, J. Am. Chem. Soc., 1997, 119, 8809–8816 CrossRefCAS.
D. A. Ostlind, T. Felcetto, A. Misura, J. Ondeyka, S. Smith, M. Goetz, W. Shoop and W. Mickle, Med. Vet. Entomol., 1997, 11, 407–408 CrossRefCAS.
J. G. Ondeyka, A. M. Dahl-Roshak, J. S. Tkacz, D. L. Zink, M. Zakson-Aiken, W. L. Shoop, M. A. Goetz and S. B. Singh, Bioorg. Med. Chem. Lett., 2002, 12, 2941–2944 CrossRefCAS.
J. G. Ondeyka, K. Byrne, D. Vesey, D. L. Zink, W. L. Shoop, M. A. Goetz and S. B. Singh, J. Nat. Prod., 2003, 66, 121–124 CrossRefCAS.
S. B. Singh, J. G. Ondeyka, H. Jayasuriya, D. L. Zink, S. N. Ha, A. Dahl-Roshak, J. Greene, J. A. Kim, M. M. Smith, W. Shoop and J. S. Tkacz, J. Nat. Prod., 2004, 67, 1496–1506 CrossRefCAS.
K. M. Byrne, S. K. Smith and J. G. Ondeyka, J. Am. Chem. Soc., 2002, 124, 7055–7060 CrossRefCAS.
B. Bhat, D. M. Harrison and H. M. Lamont, Tetrahedron, 1993, 49, 10663–10668 CrossRefCAS.
R. Marchelli, A. Dossena and G. Casnati, J. Chem. Soc., Chem. Commun., 1975, 779–780 RSC.
C. W. Holzapfel and D. C. Wilkins, Phytochemistry, 1971, 10, 351–358 CrossRefCAS.
R. M. McGrath, P. S. Steyn, N. P. Ferreira and D. C. Neethling, Bioorg. Chem., 1976, 5, 11–23 CrossRefCAS.
E. M. Stocking and R. M. Williams, Angew. Chem., Int. Ed., 2003, 42, 3078–3115 CrossRefCAS.
P. G. Mantle, Phytochemistry, 2009, 70, 7–10 CrossRefCAS.
A. E. De Jesus, C. P. Gorst-Allman, P. S. Steyn, F. R. van Heerden, R. Vleggaar, P. L. Wessels and W. E. Hull, J. Chem. Soc., Perkin Trans. 1, 1983, 1863–1868 RSC.
O. Rigbers and S.-M. Li, J. Biol. Chem., 2008, 283, 26859–26868 CrossRefCAS.
I. A. Unsöld and S.-M. Li, Microbiology, 2005, 151, 1499–1505 CrossRef.
C. M. Coyle, S. C. Kenaley, W. R. Rittenour and D. G. Panaccione, Mycologia, 2007, 99, 804–811 Search PubMed.
U. Metzger, C. Schall, G. Zocher, I. Unsold, E. Stec, S.-M. Li, L. Heide and T. Stehle, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 14309–14314 CrossRefCAS.
X. Liu, L. Wang, N. Steffan, W.-B. Yin and S.-M. Li, ChemBioChem, 2009, 10, 2325–2328 CrossRefCAS.
I. A. Unsöld and S.-M. Li, ChemBioChem, 2006, 7, 158–164 CrossRef.
N. Steffan, A. Grundmann, A. Afiyatullov, H. Ruan and S.-M. Li, Org. Biomol. Chem., 2009, 7, 4082–4087 RSC.
S. Maiya, A. Grundmann, S.-M. Li and G. Turner, ChemBioChem, 2006, 7, 1062–1069 CrossRefCAS.
C. B. Cui, H. Kakeya and H. Osada, J. Antibiot., 1996, 49, 534–540 CAS.
N. Kato, H. Suzuki, H. Takagi, Y. Asami, H. Kakeya, M. Uramoto, T. Usui, S. Takahashi, Y. Sugimoto and H. Osada, ChemBioChem, 2009, 10, 920–928 CrossRefCAS.
A. Grundmann, T. Kuznetsova, S. S. Afiyatullov and S.-M. Li, ChemBioChem, 2008, 9, 2059–2063 CrossRefCAS.
C. J. Balibar and C. T. Walsh, Biochemistry, 2006, 45, 15029–15038 CrossRefCAS.
C. J. Balibar, A. R. Howard-Jones and C. T. Walsh, Nat. Chem. Biol., 2007, 3, 584–592 CrossRefCAS.
P. Schneider, M. Weber and D. Hoffmeister, Fungal Genet. Biol., 2008, 45, 302–309 CrossRefCAS.
M. Tokuoka, Y. Seshime, I. Fujii, K. Kitamoto, T. Takahashi and Y. Koyama, Fungal Genet. Biol., 2008, 45, 1608–1615 CrossRefCAS.
P. K. Chang, B. W. Horn and J. W. Dorner, Fungal Genet. Biol., 2009, 46, 176–182 CrossRefCAS.
X. Liu and C. T. Walsh, Biochemistry, 2009, 48, 8746–8757 CrossRefCAS.
Y. Seshime, P. R. Juvvadi, M. Tokuoka, Y. Koyama, K. Kitamoto, Y. Ebizuka and I. Fujii, Bioorg. Med. Chem. Lett., 2009, 19, 3288–3292 CrossRefCAS.
C. Young, L. McMillan, E. Telfer and B. Scott, Mol. Microbiol., 2001, 39, 754–764 CrossRefCAS.
S. Saikia, E. J. Parker, A. Koulman and B. Scott, FEBS Lett., 2006, 580, 1625–1630 CrossRefCAS.
S. Saikia, E. J. Parker, A. Koulman and B. Scott, J. Biol. Chem., 2007, 282, 16829–16837 CrossRefCAS.
C. A. Young, S. Felitti, K. Shields, G. Spangenberg, R. D. Johnson, G. T. Bryan, S. Saikia and B. Scott, Fungal Genet. Biol., 2006, 43, 679–693 CrossRefCAS.
C. A. Young, M. K. Bryant, M. J. Christensen, B. A. Tapper, G. T. Bryan and B. Scott, Mol. Genet. Genomics, 2005, 274, 13–29 CrossRef.
C. A. Young, B. A. Tapper, K. May, C. D. Moon, C. L. Schardl and B. Scott, Appl. Environ. Microbiol., 2009, 75, 2200–2211 CrossRefCAS.
S. Zhang, B. J. Monahan, J. S. Tkacz and B. Scott, Appl. Environ. Microbiol., 2004, 70, 6875–6883 CrossRefCAS.
L. Heide, Curr. Opin. Chem. Biol., 2009, 13, 171–179 CrossRefCAS.
W.-B. Yin, H.-L. Ruan, L. Westrich, A. Grundmann and S.-M. Li, ChemBioChem, 2007, 8, 1154–1161 CrossRefCAS.
A. Kremer, L. Westrich and S.-M. Li, Microbiology, 2007, 153, 3409–3416 CrossRefCAS.
N. Steffan, I. A. Unsöld and S.-M. Li, ChemBioChem, 2007, 8, 1298–1307 CrossRefCAS.
A. Kremer and S.-M. Li, Appl. Microbiol. Biotechnol., 2008, 79, 951–961 CrossRefCAS.
N. Steffan and S.-M. Li, Arch. Microbiol., 2009, 191, 461–466 CrossRefCAS.
H. Zou, X. Zheng and S.-M. Li, J. Nat. Prod., 2009, 72, 44–52 CrossRefCAS.
H.-L. Ruan, E. Stec and S.-M. Li, Arch. Microbiol., 2009, 191, 791–795 CrossRefCAS.
L. Wang, W.-B. Yin, S.-M. Li and X.-Q. Liu, Chin. J. Biochem. Mol. Biol., 2009, 25, 580–584 Search PubMed.
M. E. van Apeldoorn, H. P. van Egmond, G. J. Speijers and G. J. Bakker, Mol. Nutr. Food Res., 2007, 51, 7–60 CrossRefCAS.
Y. Hitotsuyanagi, H. Fujiki, M. Suganuma, N. Aimi, S. Sakai, Y. Endo, K. Shudo and T. Sugimura, Chem. Pharm. Bull., 1984, 32, 4233–4236 CAS.
S. Sakai, N. Aimi, K. Yamaguchi, Y. Hitotsuyanagi, C. Watanabe, K. Yokose, Y. Koyama, K. Shudo and A. Itai, Chem. Pharm. Bull., 1984, 32, 354–357 CAS.
K. Irie, A. Funaki, K. Koshimizu, H. Hayashi and M. Arai, Tetrahedron Lett., 1989, 30, 2113–2116 CrossRefCAS.
K. Irie and K. Koshimizu, Comments Agric. Food Chem., 1993, 3, 1–25 Search PubMed.
K. Irie, S. Kajiyama, A. Funaki, K. Koshimizu, H. Hayashi and M. Arai, Tetrahedron, 1990, 46, 2773–2788 CrossRefCAS.
D. J. Edwards and W. H. Gerwick, J. Am. Chem. Soc., 2004, 126, 11432–11433 CrossRefCAS.
J. A. Read and C. T. Walsh, J. Am. Chem. Soc., 2007, 129, 15762–15763 CrossRefCAS.
A. Raveh and S. Carmeli, J. Nat. Prod., 2007, 70, 196–201 CrossRefCAS.
J. S. Carlé and C. Christophersen, J. Am. Chem. Soc., 1979, 101, 4012–4013 CrossRefCAS.
L. Peters, G. M. König, A. D. Wright, R. Pukall, E. Stackebrandt, L. Eberl and K. Riedel, Appl. Environ. Microbiol., 2003, 69, 3469–3475 CrossRefCAS.
L. Peters, A. D. Wright, S. Kehraus, D. Gundisch, M. C. Tilotta and G. M. König, Planta Med., 2004, 70, 883–886 CrossRefCAS.
L. Peters, G. M. Konig, H. Terlau and A. D. Wright, J. Nat. Prod., 2002, 65, 1633–1637 CrossRefCAS.
N. Lysek, E. Rachor and T. Lindel, Z. Naturforsch., C: J. Biosci., 2002, 57, 1056–1061 Search PubMed.
H. J. Knölker and K. R. Reddy, Alkaloids: Chem. Biol., 2008, 65, 1–410 Search PubMed.
Y. S. Wang, H. P. He, Y. M. Shen, X. Hong and X. J. Hao, J. Nat. Prod., 2003, 66, 416–418 CrossRefCAS.
R. S. Ramsewak, M. G. Nair, G. M. Strasburg, D. L. DeWitt and J. L. Nitiss, J. Agric. Food Chem., 1999, 47, 444–447 CrossRefCAS.
P. Tudzynski, K. Holter, T. Correia, C. Arntz, N. Grammel and U. Keller, Mol. Gen. Genet., 1999, 261, 133–141 CrossRefCAS.
T. E. Cleveland, J. Yu, N. Fedorova, D. Bhatnagar, G. A. Payne, W. C. Nierman and J. W. Bennett, Trends Biotechnol., 2009, 27, 151–157 CrossRefCAS.